153 related articles for article (PubMed ID: 37151155)
1. The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Survey About Specific Clinical Scenarios (Version 2023.1).
Kim MS; Go SI; Wee CW; Lee MH; Kang SG; Go KO; Kwon SM; Kim W; Dho YS; Park SH; Seo Y; Song SW; Ahn S; Oh HJ; Yoon HI; Lee SW; Lee JH; Cho KR; Choi JW; Hong JB; Hwang K; Park CK; Lim DH;
Brain Tumor Res Treat; 2023 Apr; 11(2):133-139. PubMed ID: 37151155
[TBL] [Abstract][Full Text] [Related]
2. The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.1).
Kim MS; Go SI; Wee CW; Lee MH; Kang SG; Go KO; Kwon SM; Kim W; Dho YS; Park SH; Seo Y; Song SW; Ahn S; Oh HJ; Yoon HI; Lee SW; Lee JH; Cho KR; Choi JW; Hong JB; Hwang K; Park CK; Lim DH;
Brain Tumor Res Treat; 2023 Apr; 11(2):123-132. PubMed ID: 37151154
[TBL] [Abstract][Full Text] [Related]
3. The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01.
Kim YZ; Kim CY; Wee CW; Roh TH; Hong JB; Oh HJ; Kang SG; Kang SH; Kong DS; Kim SH; Kim SH; Kim SH; Kim YJ; Kim EH; Kim IA; Kim HS; Park JS; Park HJ; Song SW; Sung KS; Yang SH; Yoon WS; Yoon HI; Lee J; Lee ST; Lee SW; Lee YS; Lim J; Chang JH; Jung TY; Jung HL; Cho JH; Choi SH; Choi HS; Lim DH; Chung DS;
Brain Tumor Res Treat; 2019 Oct; 7(2):74-84. PubMed ID: 31686437
[TBL] [Abstract][Full Text] [Related]
4. The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01.
Kim YZ; Kim CY; Lim J; Sung KS; Lee J; Oh HJ; Kang SG; Kang SH; Kong DS; Kim SH; Kim SH; Kim SH; Kim YJ; Kim EH; Kim IA; Kim HS; Roh TH; Park JS; Park HJ; Song SW; Yang SH; Yoon WS; Yoon HI; Lee ST; Lee SW; Lee YS; Wee CW; Chang JH; Jung TY; Jung HL; Cho JH; Choi SH; Choi HS; Hong JB; Lim DH; Chung DS;
Brain Tumor Res Treat; 2019 Oct; 7(2):63-73. PubMed ID: 31686436
[TBL] [Abstract][Full Text] [Related]
5. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
Mohile NA; Messersmith H; Gatson NT; Hottinger AF; Lassman A; Morton J; Ney D; Nghiemphu PL; Olar A; Olson J; Perry J; Portnow J; Schiff D; Shannon A; Shih HA; Strowd R; van den Bent M; Ziu M; Blakeley J
J Clin Oncol; 2022 Feb; 40(4):403-426. PubMed ID: 34898238
[TBL] [Abstract][Full Text] [Related]
6. The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01.
Kim YZ; Kim CY; Lim J; Sung KS; Lee J; Oh HJ; Kang SG; Kang SH; Kong DS; Kim SH; Kim SH; Kim SH; Kim YJ; Kim EH; Kim IA; Kim HS; Roh TH; Park JS; Park HJ; Song SW; Yang SH; Yoon WS; Yoon HI; Lee ST; Lee SW; Lee YS; Wee CW; Chang JH; Jung TY; Jung HL; Cho JH; Choi SH; Choi HS; Hong JB; Lim DH; Chung DS;
Brain Tumor Res Treat; 2019 Apr; 7(1):1-9. PubMed ID: 31062525
[TBL] [Abstract][Full Text] [Related]
7. A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma.
Kim SK; Yoon HI; Yoon WS; Cho JM; Moon J; Kim KH; Kim SH; Kim YI; Kim YZ; Kim HS; Dho YS; Park JS; Park JE; Seo Y; Sung KS; Song JH; Wee CW; Lee SH; Lim DH; Im JH; Chang JH; Han MH; Hong JB; Hwang K; Park CK; Lee YS; Gwak HS;
Brain Tumor Res Treat; 2020 Apr; 8(1):11-19. PubMed ID: 32390349
[TBL] [Abstract][Full Text] [Related]
8. The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1.
Moon J; Kim MS; Kim YZ; Hwang K; Park JE; Kim KH; Cho JM; Yoon WS; Kim SH; Kim YI; Kim HS; Dho YS; Park JS; Yoon HI; Seo Y; Sung KS; Song JH; Wee CW; Lee MH; Han MH; Hong JB; Im JH; Lee SH; Chang JH; Lim DH; Park CK; Lee YS; Gwak HS;
Brain Tumor Res Treat; 2021 Apr; 9(1):9-15. PubMed ID: 33913266
[TBL] [Abstract][Full Text] [Related]
9. The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1.
Yoon HI; Wee CW; Kim YZ; Seo Y; Im JH; Dho YS; Kim KH; Hong JB; Park JS; Choi SH; Kim MS; Moon J; Hwang K; Park JE; Cho JM; Yoon WS; Kim SH; Kim YI; Kim HS; Sung KS; Song JH; Lee MH; Han MH; Lee SH; Chang JH; Lim DH; Park CK; Lee YS; Gwak HS;
Brain Tumor Res Treat; 2021 Apr; 9(1):1-8. PubMed ID: 33913265
[TBL] [Abstract][Full Text] [Related]
10. A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma.
Kim SK; Park JE; Kim KH; Cho JM; Moon J; Yoon WS; Kim SH; Kim YI; Kim YZ; Kim HS; Dho YS; Park JS; Yoon HI; Seo Y; Sung KS; Song JH; Wee CW; Lee SH; Lim DH; Im JH; Chang JH; Han MH; Hong JB; Hwang K; Park CK; Lee YS; Gwak HS;
Brain Tumor Res Treat; 2020 Apr; 8(1):20-28. PubMed ID: 32390350
[TBL] [Abstract][Full Text] [Related]
11. A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage.
Kim SK; Moon J; Cho JM; Kim KH; Kim SH; Kim YI; Kim YZ; Kim HS; Dho YS; Park JS; Park JE; Seo Y; Sung KS; Song JH; Wee CW; Yoon WS; Yoon HI; Lee SH; Lim DH; Im JH; Chang JH; Han MH; Hong JB; Hwang K; Park CK; Lee YS; Gwak HS;
Brain Tumor Res Treat; 2020 Apr; 8(1):1-10. PubMed ID: 32390348
[TBL] [Abstract][Full Text] [Related]
12. Management of single brain metastasis: a practice guideline.
Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
[TBL] [Abstract][Full Text] [Related]
13. Current trend of radiotherapy for glioblastoma in the elderly: a survey study by the brain tumor Committee of the Korean Radiation Oncology Group (KROG 21-05).
Wee CW; In Yoon H; Lee SW; Lim DH
Jpn J Clin Oncol; 2022 Aug; 52(8):843-849. PubMed ID: 35453150
[TBL] [Abstract][Full Text] [Related]
14. The Overview of Practical Guidelines for Gliomas by KSNO, NCCN, and EANO.
Kim YZ; Kim CY; Lim DH
Brain Tumor Res Treat; 2022 Apr; 10(2):83-93. PubMed ID: 35545827
[TBL] [Abstract][Full Text] [Related]
15. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
[TBL] [Abstract][Full Text] [Related]
16. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
Sulman EP; Ismaila N; Armstrong TS; Tsien C; Batchelor TT; Cloughesy T; Galanis E; Gilbert M; Gondi V; Lovely M; Mehta M; Mumber MP; Sloan A; Chang SM
J Clin Oncol; 2017 Jan; 35(3):361-369. PubMed ID: 27893327
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
[TBL] [Abstract][Full Text] [Related]
19. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
20. Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme.
Greer L; Pannullo SC; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Wernicke AG
Cureus; 2017 Jun; 9(6):e1388. PubMed ID: 28775928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
